Pacira Pharmaceuticals, Inc. Reports Third Quarter 2016 Financial Results
Nov 02, 2016 11:30 am UTC| Business
-- Total Net Revenues Up 10% Year-Over-Year ---- EXPAREL® Net Product Sales Up 9% Year-Over-Year ---- Conference Call Today at 9 a.m. ET -- PARSIPPANY, N.J., Nov. 02, 2016 -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX)...
CNinsure Inc. to Hold Extraordinary General Meeting on December 6, 2016
Nov 02, 2016 11:30 am UTC| Business
GUANGZHOU, China, Nov. 02, 2016 -- CNinsure Inc. (Nasdaq:CISG) (the "Company" or "CNinsure"), a leading independent online-to-offline financial services provider operating in China, today announced that it will hold an...
Otonomy Announces Assignment of J Code for OTIPRIO®
Nov 02, 2016 11:30 am UTC| Business
SAN DIEGO, Nov. 02, 2016 -- Otonomy, Inc. (Nasdaq:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today announced...
Cidara Therapeutics and Square 1 Bank Announce $20 Million Credit Facility
Nov 02, 2016 11:30 am UTC| Business
SAN DIEGO, Nov. 02, 2016 -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other infections, and Square 1 Bank, a division of...
iCAD Reports Third Quarter 2016 Financial Results
Nov 02, 2016 11:30 am UTC| Business
NASHUA, N.H., Nov. 02, 2016 -- iCAD, Inc. (Nasdaq:ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today...
MGP Ingredients Reports Third Quarter Results
Nov 02, 2016 11:30 am UTC| Business
ATCHISON, Kan., Nov. 02, 2016 -- MGPIngredients, Inc. (Nasdaq:MGPI), a leading supplier of premium distilled spirits and specialty wheat proteins and starches, today reported results for the third quarter ended...
Nov 02, 2016 11:30 am UTC| Business
Successfully demonstrated proof-of-principle in a Phase 1b study of oral and IV omadacycline in patients with urinary tract infections (UTI)Completed all clinical phase 1 studies and registration batches required for NDA...